Vanguard Group Inc. Boosts Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Vanguard Group Inc. grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 7.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,689,396 shares of the company's stock after purchasing an additional 784,818 shares during the period. Vanguard Group Inc. owned about 2.79% of LifeStance Health Group worth $78,781,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. Blue Trust Inc. increased its holdings in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after acquiring an additional 2,122 shares during the last quarter. R Squared Ltd bought a new stake in shares of LifeStance Health Group during the fourth quarter worth approximately $80,000. Cibc World Markets Corp acquired a new stake in LifeStance Health Group during the 4th quarter worth approximately $96,000. Handelsbanken Fonder AB bought a new stake in LifeStance Health Group in the 4th quarter valued at $128,000. Finally, Versor Investments LP acquired a new position in LifeStance Health Group in the 4th quarter valued at $131,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company's stock, valued at $2,344,689. The trade was a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 6.60% of the stock is owned by insiders.

Remove Ads

Analyst Ratings Changes

LFST has been the subject of several analyst reports. KeyCorp assumed coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective for the company. William Blair restated an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. Finally, Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 target price for the company. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $8.58.

LifeStance Health Group Stock Down 0.7 %

Shares of LFST traded down $0.05 during trading hours on Wednesday, hitting $6.78. The stock had a trading volume of 52,593 shares, compared to its average volume of 1,602,712. The firm has a 50 day simple moving average of $7.23 and a 200-day simple moving average of $7.33. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $8.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market capitalization of $2.61 billion, a P/E ratio of -26.06 and a beta of 1.30.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.